BR9714253A - Forma de dosagem farmacêutica de libertação rápida e dissimuladora do sabor - Google Patents

Forma de dosagem farmacêutica de libertação rápida e dissimuladora do sabor

Info

Publication number
BR9714253A
BR9714253A BR9714253-0A BR9714253A BR9714253A BR 9714253 A BR9714253 A BR 9714253A BR 9714253 A BR9714253 A BR 9714253A BR 9714253 A BR9714253 A BR 9714253A
Authority
BR
Brazil
Prior art keywords
dosage form
quick release
pharmaceutical dosage
taste
coating layer
Prior art date
Application number
BR9714253-0A
Other languages
English (en)
Inventor
Akinori Itoh
Toshiyuki Niwa
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9714253A publication Critical patent/BR9714253A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Abstract

Patente de Invenção: <B>''FORMA DE DOSAGEM FARMACêUTICA DE LIBERTAçãO RáPIDA E DISSIMULADORA DO SABOR''<D>. A presente invenção refere-se uma forma de dosagem farmacêutica de libertação rápida e dissimuladora do sabor que compreende um núcleo que contém um ingrediente farmaceuticamente ativo, hidroxipropil celulose substituída inferiormente e celulose microcristalina, em que a quantidade da celulose microcristalina é de pelo menos 26,0 por cento em peso com base no peso total do núcleo; uma camada de revestimento interior formada sobre o núcleo e que contém um polímero solúvel em água; e uma camada de revestimento exterior formada sobre a camada de revestimento interior e que contém um polímero insolúvel na saliva. A presente invenção também refere-se a um processo para a preparação desta forma de dosagem oral.
BR9714253-0A 1997-01-06 1997-11-20 Forma de dosagem farmacêutica de libertação rápida e dissimuladora do sabor BR9714253A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB9700003 1997-01-06
PCT/IB1997/001471 WO1998030209A1 (en) 1997-01-06 1997-11-20 Rapidly releasing and taste-masking pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
BR9714253A true BR9714253A (pt) 2000-04-18

Family

ID=11004515

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714253-0A BR9714253A (pt) 1997-01-06 1997-11-20 Forma de dosagem farmacêutica de libertação rápida e dissimuladora do sabor

Country Status (36)

Country Link
EP (1) EP0941075B1 (pt)
JP (1) JP3350059B2 (pt)
KR (1) KR20000069899A (pt)
CN (1) CN1244119A (pt)
AP (1) AP802A (pt)
AR (1) AR008553A1 (pt)
AT (1) ATE238776T1 (pt)
AU (1) AU715867B2 (pt)
BG (1) BG103541A (pt)
BR (1) BR9714253A (pt)
CA (1) CA2277017C (pt)
CO (1) CO4650099A1 (pt)
DE (1) DE69721559T2 (pt)
DK (1) DK0941075T3 (pt)
EA (1) EA199900521A1 (pt)
ES (1) ES2192265T3 (pt)
HN (1) HN1997000151A (pt)
HR (1) HRP980005A2 (pt)
HU (1) HUP0002744A3 (pt)
ID (1) ID21806A (pt)
IL (1) IL130582A0 (pt)
IS (1) IS5095A (pt)
MA (1) MA26464A1 (pt)
NO (1) NO993315L (pt)
NZ (1) NZ336251A (pt)
OA (1) OA11072A (pt)
PA (1) PA8443301A1 (pt)
PE (1) PE27999A1 (pt)
PL (1) PL334439A1 (pt)
SK (1) SK89599A3 (pt)
TN (1) TNSN98002A1 (pt)
TR (1) TR199901564T2 (pt)
UY (1) UY24835A1 (pt)
WO (1) WO1998030209A1 (pt)
YU (1) YU31599A (pt)
ZA (1) ZA9829B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) * 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
UA67802C2 (uk) 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
EP2260836B1 (en) * 1998-11-25 2016-08-10 Cima Labs Inc. Rapid release tablet with coated drug-containing core and surrounding taste masking layer
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
NZ524572A (en) 2000-09-06 2004-08-27 Tanabe Seiyaku Co Oral compositions comprising phosphodiesterase inhibitors ( PDE inhibitor )and an acidic substance such as fumaric acid with improved drug efficacy due to decrease solubility in neutral and alkaline regions
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
EP1728791A4 (en) 2004-03-25 2008-12-10 Astellas Pharma Inc COMPOSITIONS FOR SOLID PHARMACEUTICAL PREPARATION OF SOLIFENACIN OR BZW. A SALT OF IT
BG66010B1 (bg) * 2004-12-08 2010-10-29 "Софарма" Ад Лекарствена форма на силденафил
DE602006020642D1 (de) * 2005-01-06 2011-04-21 Cima Labs Inc Geschmacksunterdrückungssystem für nicht weichgemachte Arzneimittel
JPWO2007010930A1 (ja) * 2005-07-20 2009-01-29 アステラス製薬株式会社 口腔内崩壊製剤用の薬物含有被覆微粒子及びその製造方法
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
JP2007031407A (ja) 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
JP4602949B2 (ja) * 2006-08-02 2010-12-22 和光堂株式会社 被覆粒子含有組成物及びその製造方法
JPWO2008059881A1 (ja) * 2006-11-14 2010-03-04 サンスター株式会社 水溶性物質で表面処理された結晶セルロースを含む口腔用組成物
JP5777273B2 (ja) * 2008-07-10 2015-09-09 大正製薬株式会社 不快な呈味を有する薬物を含有する製剤粒子
JP4706785B2 (ja) * 2008-09-30 2011-06-22 アステラス製薬株式会社 経口投与用粒子状医薬組成物
US20110244050A1 (en) 2008-12-12 2011-10-06 Siegfried Rhein S.A. De C.V. Pulsed-release sildenafil composition and method for preparing said composition
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
WO2011081199A1 (ja) * 2009-12-28 2011-07-07 ニプロ株式会社 品質が向上した経口剤
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
TWI462739B (zh) * 2010-11-02 2014-12-01 Univ Kaohsiung Medical Ｓｉｌｄｅｎａｆｉｌ－同族物四級銨哌嗪鹽類之製備及醫療用途
GB201119985D0 (en) * 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
CN103271940B (zh) * 2013-05-03 2014-03-12 湖北新济药业有限公司 复方金属离子补充剂及其制备方法
WO2017146052A1 (ja) * 2016-02-23 2017-08-31 ニプロ株式会社 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
WO2020045456A1 (ja) * 2018-08-28 2020-03-05 東和薬品株式会社 薬物含有粒子
CN113559070B (zh) * 2021-08-18 2022-12-06 广州中冠动物药业有限公司 一种适用于宠物咳嗽的药物制备方法
CN116139088B (zh) * 2023-01-31 2024-04-16 南京海纳医药科技股份有限公司 一种含有枸橼酸西地那非的干混悬剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258809A (ja) * 1987-04-16 1988-10-26 Towa Yakuhin Kk 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
EP0458751A1 (en) * 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
JP2576927B2 (ja) * 1992-05-15 1997-01-29 ファイザー製薬株式会社 細粒核
US5817338A (en) * 1994-07-08 1998-10-06 Astra Aktiebolag Multiple unit tableted dosage form of omeprazole

Also Published As

Publication number Publication date
CA2277017C (en) 2002-11-26
CA2277017A1 (en) 1998-07-16
YU31599A (sh) 2000-03-21
HUP0002744A3 (en) 2001-01-29
MA26464A1 (fr) 2004-12-20
PL334439A1 (en) 2000-02-28
ES2192265T3 (es) 2003-10-01
ID21806A (id) 1999-07-29
CN1244119A (zh) 2000-02-09
NZ336251A (en) 2001-01-26
BG103541A (en) 2000-03-31
EP0941075A1 (en) 1999-09-15
NO993315D0 (no) 1999-07-05
ZA9829B (en) 1999-07-05
PA8443301A1 (es) 2000-05-24
PE27999A1 (es) 1999-03-12
AU4880897A (en) 1998-08-03
JP3350059B2 (ja) 2002-11-25
WO1998030209A1 (en) 1998-07-16
HRP980005A2 (en) 1998-10-31
EP0941075B1 (en) 2003-05-02
DE69721559D1 (de) 2003-06-05
OA11072A (en) 2002-02-27
AP802A (en) 2000-01-21
TNSN98002A1 (fr) 2005-03-15
SK89599A3 (en) 2000-12-11
AR008553A1 (es) 2000-01-19
NO993315L (no) 1999-07-05
HUP0002744A2 (hu) 2000-12-28
KR20000069899A (ko) 2000-11-25
CO4650099A1 (es) 1998-09-03
JP2000514830A (ja) 2000-11-07
DK0941075T3 (da) 2003-07-14
DE69721559T2 (de) 2003-11-27
IL130582A0 (en) 2000-06-01
IS5095A (is) 1999-06-25
AU715867B2 (en) 2000-02-10
TR199901564T2 (xx) 1999-09-21
UY24835A1 (es) 2000-09-29
EA199900521A1 (ru) 1999-12-29
ATE238776T1 (de) 2003-05-15
HN1997000151A (es) 1997-12-20
AP9801173A0 (en) 1998-01-31

Similar Documents

Publication Publication Date Title
BR9714253A (pt) Forma de dosagem farmacêutica de libertação rápida e dissimuladora do sabor
EE200100505A (et) Modifitseeritud tärklise kasutamine hüdrofiilses kontrollitud vabanemisega preparaadis, hüdrofiilnekontrollitud vabanemisega preparaat, selle valmistamismeetod ja kasutamine ning ravimvorm
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
BRPI0513300A (pt) forma farmacêutica oral, protegida frente ao abuso, contendo (1r, 2r)-3-(3-dimetilamino-1-etil-2-propil)-fenol
KR910004180A (ko) 저작성 약제학적 정제를 제조하기 위한 회전과립화 공정 및 맛을 은폐하기 위한 피복공정
BRPI0411986A (pt) forma de dosagem farmacêutica multiparticulada, contendo substáncias peptìdicas ou protéicas ativas formuladas de maneira mucoadesiva, e um método para produzir a dita forma de dosagem farmacêutica
BR9904039A (pt) Preparação de partìculas farmaceuticamente ativas
TR199800894T2 (xx) Biyo-yap��kan kat� dozaj formlar�.
TR200003788A2 (tr) Yavaş salımlı oral dozaj bileşim.
BR9811249A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
BR0012326A (pt) Formulações lìquidas farmacêuticas de gosto mascarado
FR2752732B1 (fr) Forme galenique a liberation prolongee de milnacipran
CA2337046A1 (en) Sustained release pharmaceutical preparation
BR9807368A (pt) Comprimidos de oxacarvazepina revestidos com pelìcula
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
BR9915111A (pt) Partìculas revestidas de ibuprofeno cristalinogranulado
BR0202491A (pt) Forma de dosagem de núcleo macio, de revestimento frágil
BR0114100A (pt) Formulações de liberação controlada para administração oral
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
BR9810337A (pt) Utilização de um antagonista especìfico dos receptores 5ht2 para a preparação de medicamentos úteis no tratamento da sìndrome de apnéia do sono
BR0012822A (pt) Formulação farmacêutica, e, forma de dosagem em tablete
BR9508202A (pt) Forma medicinal de carbamazepina com liberação de substáncia atíva retardada
PT1265614E (pt) Nova forma galenica para administracao oral de libertacao prolongada de molsidomina
BR0215707A (pt) Composição farmacêutica para a liberação controlada de ingredientes ativos e processo para a preparação de uma composição farmacêutica
BR0115206A (pt) Composições hidroliticamente instáveis

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO PELO PRESENTE PEDIDO DE PATENTE DE ACORDO COM ARTIGO 8O DA LPI.